Catalyst Wire Dossier Catalyst Wire Dossier

AM3

· Industrial Farmacéutica Cantabria, S.A.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for AM3, covering 2025-06-26 to 2025-06-26. Get the full timeline:

Most recent: Clinical Trial Update: A Pilot Study to Evaluate the Systemic Effect of Oral Supplementation With AM3 in Patients With Metabolic Syndrome. [NA]

See pricing